By Scott Graham | February 6, 2018
In an appellate showdown between Fish & Richardson's Juanita Brooks and MoloLamken's Jeffrey Lamken, a Federal Circuit panel seemed swayed by Merck's argument that one bad witness didn't taint the jury's verdict.
By Kristen Rasmussen | January 30, 2018
Driven largely by plaintiffs firms Pomerantz & Co., The Rosen Law Firm and Glancy Prongay & Murray, shareholder class-action lawsuits against life sciences companies, particularly those in the pharmaceutical space, were on the rise last year, continuing a decade-long trend, according to a new report.
By Sue Reisinger | January 25, 2018
The global general counsel job will move from Philadelphia, where Troy is based, to the United Kingdom, where the company has its headquarters.
By Kristen Rasmussen | January 22, 2018
South San Francisco-based MyoKardia Inc. has hired Cynthia Ladd as general counsel. Ladd has held high-ranking in-house positions at various biopharmaceutical companies.
By Kristen Rasmussen | January 18, 2018
An Aetna Inc. shareholder has sued to block the proposed $69 billion takeover by CVS Health, claiming that the "unfair and inadequate" deal would shortchange shareholders.
By Kristen Rasmussen | January 16, 2018
Health care companies need to be mindful of the U.S. Department of Justice's continued enforcement of the False Claims Act but also pay attention to areas such as drug pricing and opioids that may be the focus of increased scrutiny in 2018, according to the health care portion of Crowell & Moring's annual Litigation Forecast.
By Kristen Rasmussen | January 8, 2018
An FDA guru and senior policy adviser at Akin Gump Strauss Hauer & Feld explain what's to come in the health care space 2018.
By Amanda Bronstad | January 4, 2018
A federal judge has approved a plaintiffs leadership team in the opioid litigation that's expected to get bigger—much bigger.
By Kristen Rasmussen | January 2, 2018
Kmart Corp. has agreed to pay $32.3 million to the United States to settle allegations in a qui tam lawsuit that in-store pharmacies overcharged several federal health care programs, the U.S. Department of Justice has announced.
By Charles Toutant | December 22, 2017
The former CEO of Valeant Pharmaceuticals has been ordered to submit to binding arbitration his dispute with the company over allegedly unpaid stock options.
Presented by BigVoodoo
General Counsel Summit is the premier event for in-house counsel, hosting esteemed legal minds from all sectors of the economy.
Join General Counsel and Senior Legal Leaders at the Premier Forum Designed For and by General Counsel from Fortune 1000 Companies
WIPL is the original global forum facilitating women-to-women exchange on leadership and legal issues.
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS